Takeover

Acquirers

Indivior Pharmaceuticals, Inc.

Targets
1
Filings
1
Median premium
44%
First filing
Sep 11, 2026
Latest filing
Sep 11, 2026

Targets

CompanyTakeover scoreFilingsLatest
SUPNSUPERNUS PHARMACEUTICALS, INC.51Sep 11, 2026

Deal filings

FiledCompanyFormPricePremium
Sep 11, 2026SUPNSUPERNUS PHARMACEUTICALS, INC.DEFM14A$40.7343.5%